Hepatitis B is a viral infection caused due to transmission of the virus through contact with the blood or other body fluids of an infected person. It is considered as a serious occupational hazard for healthcare professionals, which affects the liver, causing acute and chronic diseases. Hence, Chinese hamster ovary cell (CHO) hepatitis B vaccine is considered to be the safe and effective method to prevent the hepatitis B infection. The major factor that fuels the growth of the market are increase in prevalence of hepatitis B infection worldwide. For example, approximately 887,000 deaths due to hepatitis B infection were recorded in 2015 across the globe. However, inherent disadvantages of using recombinant Chinese hamster ovary cell (CHO) to design hepatitis B vaccines restrains the growth of the market. Conversely, increase in government focus to promote (CHO) hepatitis B vaccination for adults and extensive research carried out for the same are expected to offer lucrative opportunities for the market.

The global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine.

Report Scope

The Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine market size, estimations, and forecasts are provided in terms of sales volume (K Doses) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Report

Report Metric	Details
Report Name	Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market
CAGR	5%
Segment by Type	Pediatric Hepatitis B (CHO) Vaccine Adult Hepatitis B (CHO) Vaccine
Segment by Application	Hospitals Clinics
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Merck & Co., Inc., GlaxoSmithKline Plc, Pfizer Inc., Sanofi Pasteur, CSL Limited, Emergent Biosolutions, Serum Institute of India, Johnson & Johnson
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market report?

Ans: The main players in the Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market are Merck & Co., Inc., GlaxoSmithKline Plc, Pfizer Inc., Sanofi Pasteur, CSL Limited, Emergent Biosolutions, Serum Institute of India, Johnson & Johnson

What are the Application segmentation covered in the Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market report?

Ans: The Applications covered in the Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market report are Hospitals, Clinics

What are the Type segmentation covered in the Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market report?

Ans: The Types covered in the Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market report are Pediatric Hepatitis B (CHO) Vaccine, Adult Hepatitis B (CHO) Vaccine

1 Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Overview

1.1 Product Overview and Scope of Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine

1.2 Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Segment by Type

1.2.1 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Value Comparison by Type (2024-2030)

1.2.2 Pediatric Hepatitis B (CHO) Vaccine

1.2.3 Adult Hepatitis B (CHO) Vaccine

1.3 Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Segment by Application

1.3.1 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Value by Application: (2024-2030)

1.3.2 Hospitals

1.3.3 Clinics

1.4 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Size Estimates and Forecasts

1.4.1 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue 2019-2030

1.4.2 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales 2019-2030

1.4.3 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Average Price (2019-2030)

1.5 Assumptions and Limitations

2 Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Competition by Manufacturers

2.1 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales Market Share by Manufacturers (2019-2024)

2.2 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue Market Share by Manufacturers (2019-2024)

2.3 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Average Price by Manufacturers (2019-2024)

2.4 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Industry Ranking 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine, Product Type & Application

2.7 Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Competitive Situation and Trends

2.7.1 Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Concentration Rate

2.7.2 The Global Top 5 and Top 10 Largest Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Players Market Share by Revenue

2.7.3 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

2.8 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Retrospective Market Scenario by Region

3.1 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Size by Region: 2019 Versus 2023 Versus 2030

3.2 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales by Region: 2019-2030

3.2.1 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales by Region: 2019-2024

3.2.2 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales by Region: 2025-2030

3.3 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue by Region: 2019-2030

3.3.1 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue by Region: 2019-2024

3.3.2 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue by Region: 2025-2030

3.4 North America Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Facts & Figures by Country

3.4.1 North America Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Size by Country: 2019 VS 2023 VS 2030

3.4.2 North America Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales by Country (2019-2030)

3.4.3 North America Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue by Country (2019-2030)

3.4.4 U.S.

3.4.5 Canada

3.5 Europe Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Facts & Figures by Country

3.5.1 Europe Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Size by Country: 2019 VS 2023 VS 2030

3.5.2 Europe Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales by Country (2019-2030)

3.5.3 Europe Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue by Country (2019-2030)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Facts & Figures by Country

3.6.1 Asia Pacific Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Size by Country: 2019 VS 2023 VS 2030

3.6.2 Asia Pacific Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales by Country (2019-2030)

3.6.3 Asia Pacific Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue by Country (2019-2030)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 Taiwan

3.6.10 Indonesia

3.6.11 Thailand

3.6.12 Malaysia

3.6.13 Philippines

3.7 Latin America Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Facts & Figures by Country

3.7.1 Latin America Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Size by Country: 2019 VS 2023 VS 2030

3.7.2 Latin America Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales by Country (2019-2030)

3.7.3 Latin America Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue by Country (2019-2030)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Facts & Figures by Country

3.8.1 Middle East and Africa Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Size by Country: 2019 VS 2023 VS 2030

3.8.2 Middle East and Africa Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales by Country (2019-2030)

3.8.3 Middle East and Africa Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue by Country (2019-2030)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 U.A.E

4 Segment by Type

4.1 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales by Type (2019-2030)

4.1.1 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales by Type (2019-2024)

4.1.2 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales by Type (2025-2030)

4.1.3 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales Market Share by Type (2019-2030)

4.2 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue by Type (2019-2030)

4.2.1 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue by Type (2019-2024)

4.2.2 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue by Type (2025-2030)

4.2.3 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue Market Share by Type (2019-2030)

4.3 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Price by Type (2019-2030)

5 Segment by Application

5.1 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales by Application (2019-2030)

5.1.1 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales by Application (2019-2024)

5.1.2 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales by Application (2025-2030)

5.1.3 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales Market Share by Application (2019-2030)

5.2 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue by Application (2019-2030)

5.2.1 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue by Application (2019-2024)

5.2.2 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue by Application (2025-2030)

5.2.3 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue Market Share by Application (2019-2030)

5.3 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Price by Application (2019-2030)

6 Key Companies Profiled

6.1 Merck & Co., Inc.

6.1.1 Merck & Co., Inc. Corporation Information

6.1.2 Merck & Co., Inc. Description and Business Overview

6.1.3 Merck & Co., Inc. Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales, Revenue and Gross Margin (2019-2024)

6.1.4 Merck & Co., Inc. Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Product Portfolio

6.1.5 Merck & Co., Inc. Recent Developments/Updates

6.2 GlaxoSmithKline Plc

6.2.1 GlaxoSmithKline Plc Corporation Information

6.2.2 GlaxoSmithKline Plc Description and Business Overview

6.2.3 GlaxoSmithKline Plc Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales, Revenue and Gross Margin (2019-2024)

6.2.4 GlaxoSmithKline Plc Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Product Portfolio

6.2.5 GlaxoSmithKline Plc Recent Developments/Updates

6.3 Pfizer Inc.

6.3.1 Pfizer Inc. Corporation Information

6.3.2 Pfizer Inc. Description and Business Overview

6.3.3 Pfizer Inc. Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales, Revenue and Gross Margin (2019-2024)

6.3.4 Pfizer Inc. Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Product Portfolio

6.3.5 Pfizer Inc. Recent Developments/Updates

6.4 Sanofi Pasteur

6.4.1 Sanofi Pasteur Corporation Information

6.4.2 Sanofi Pasteur Description and Business Overview

6.4.3 Sanofi Pasteur Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales, Revenue and Gross Margin (2019-2024)

6.4.4 Sanofi Pasteur Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Product Portfolio

6.4.5 Sanofi Pasteur Recent Developments/Updates

6.5 CSL Limited

6.5.1 CSL Limited Corporation Information

6.5.2 CSL Limited Description and Business Overview

6.5.3 CSL Limited Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales, Revenue and Gross Margin (2019-2024)

6.5.4 CSL Limited Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Product Portfolio

6.5.5 CSL Limited Recent Developments/Updates

6.6 Emergent Biosolutions

6.6.1 Emergent Biosolutions Corporation Information

6.6.2 Emergent Biosolutions Description and Business Overview

6.6.3 Emergent Biosolutions Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales, Revenue and Gross Margin (2019-2024)

6.6.4 Emergent Biosolutions Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Product Portfolio

6.6.5 Emergent Biosolutions Recent Developments/Updates

6.7 Serum Institute of India

6.6.1 Serum Institute of India Corporation Information

6.6.2 Serum Institute of India Description and Business Overview

6.6.3 Serum Institute of India Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales, Revenue and Gross Margin (2019-2024)

6.4.4 Serum Institute of India Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Product Portfolio

6.7.5 Serum Institute of India Recent Developments/Updates

6.8 Johnson & Johnson

6.8.1 Johnson & Johnson Corporation Information

6.8.2 Johnson & Johnson Description and Business Overview

6.8.3 Johnson & Johnson Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales, Revenue and Gross Margin (2019-2024)

6.8.4 Johnson & Johnson Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Product Portfolio

6.8.5 Johnson & Johnson Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Industry Chain Analysis

7.2 Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Key Raw Materials

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Production Mode & Process

7.4 Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales and Marketing

7.4.1 Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales Channels

7.4.2 Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Distributors

7.5 Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Customers

8 Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Dynamics

8.1 Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Industry Trends

8.2 Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Drivers

8.3 Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Challenges

8.4 Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Restraints

9 Research Finding and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

Emergent Biosolutions

Serum Institute of India

Johnson & Johnson

List of Tables

Table 1. Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Value Comparison by Type (2024-2030) & (US$ Million)

Table 2. Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Value Comparison by Application (2024-2030) & (US$ Million)

Table 3. Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Competitive Situation by Manufacturers in 2023

Table 4. Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales (K Doses) of Key Manufacturers (2019-2024)

Table 5. Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales Market Share by Manufacturers (2019-2024)

Table 6. Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue (US$ Million) by Manufacturers (2019-2024)

Table 7. Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue Share by Manufacturers (2019-2024)

Table 8. Global Market Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Average Price (USD/Dose) of Key Manufacturers (2019-2024)

Table 9. Global Key Players of Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine, Product Type & Application

Table 12. Global Key Manufacturers of Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine as of 2023)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 17. Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales by Region (2019-2024) & (K Doses)

Table 18. Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales Market Share by Region (2019-2024)

Table 19. Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales by Region (2025-2030) & (K Doses)

Table 20. Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales Market Share by Region (2025-2030)

Table 21. Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue by Region (2019-2024) & (US$ Million)

Table 22. Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue Market Share by Region (2019-2024)

Table 23. Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue by Region (2025-2030) & (US$ Million)

Table 24. Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue Market Share by Region (2025-2030)

Table 25. North America Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 26. North America Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales by Country (2019-2024) & (K Doses)

Table 27. North America Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales by Country (2025-2030) & (K Doses)

Table 28. North America Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue by Country (2019-2024) & (US$ Million)

Table 29. North America Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue by Country (2025-2030) & (US$ Million)

Table 30. Europe Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 31. Europe Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales by Country (2019-2024) & (K Doses)

Table 32. Europe Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales by Country (2025-2030) & (K Doses)

Table 33. Europe Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue by Country (2019-2024) & (US$ Million)

Table 34. Europe Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue by Country (2025-2030) & (US$ Million)

Table 35. Asia Pacific Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 36. Asia Pacific Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales by Region (2019-2024) & (K Doses)

Table 37. Asia Pacific Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales by Region (2025-2030) & (K Doses)

Table 38. Asia Pacific Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue by Region (2019-2024) & (US$ Million)

Table 39. Asia Pacific Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue by Region (2025-2030) & (US$ Million)

Table 40. Latin America Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 41. Latin America Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales by Country (2019-2024) & (K Doses)

Table 42. Latin America Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales by Country (2025-2030) & (K Doses)

Table 43. Latin America Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue by Country (2019-2024) & (US$ Million)

Table 44. Latin America Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue by Country (2025-2030) & (US$ Million)

Table 45. Middle East & Africa Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 46. Middle East & Africa Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales by Country (2019-2024) & (K Doses)

Table 47. Middle East & Africa Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales by Country (2025-2030) & (K Doses)

Table 48. Middle East & Africa Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue by Country (2019-2024) & (US$ Million)

Table 49. Middle East & Africa Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue by Country (2025-2030) & (US$ Million)

Table 50. Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales (K Doses) by Type (2019-2024)

Table 51. Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales (K Doses) by Type (2025-2030)

Table 52. Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales Market Share by Type (2019-2024)

Table 53. Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales Market Share by Type (2025-2030)

Table 54. Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue (US$ Million) by Type (2019-2024)

Table 55. Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue (US$ Million) by Type (2025-2030)

Table 56. Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue Market Share by Type (2019-2024)

Table 57. Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue Market Share by Type (2025-2030)

Table 58. Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Price (USD/Dose) by Type (2019-2024)

Table 59. Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Price (USD/Dose) by Type (2025-2030)

Table 60. Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales (K Doses) by Application (2019-2024)

Table 61. Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales (K Doses) by Application (2025-2030)

Table 62. Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales Market Share by Application (2019-2024)

Table 63. Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales Market Share by Application (2025-2030)

Table 64. Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue (US$ Million) by Application (2019-2024)

Table 65. Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue (US$ Million) by Application (2025-2030)

Table 66. Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue Market Share by Application (2019-2024)

Table 67. Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue Market Share by Application (2025-2030)

Table 68. Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Price (USD/Dose) by Application (2019-2024)

Table 69. Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Price (USD/Dose) by Application (2025-2030)

Table 70. Merck & Co., Inc. Corporation Information

Table 71. Merck & Co., Inc. Description and Business Overview

Table 72. Merck & Co., Inc. Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)

Table 73. Merck & Co., Inc. Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Product

Table 74. Merck & Co., Inc. Recent Developments/Updates

Table 75. GlaxoSmithKline Plc Corporation Information

Table 76. GlaxoSmithKline Plc Description and Business Overview

Table 77. GlaxoSmithKline Plc Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)

Table 78. GlaxoSmithKline Plc Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Product

Table 79. GlaxoSmithKline Plc Recent Developments/Updates

Table 80. Pfizer Inc. Corporation Information

Table 81. Pfizer Inc. Description and Business Overview

Table 82. Pfizer Inc. Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)

Table 83. Pfizer Inc. Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Product

Table 84. Pfizer Inc. Recent Developments/Updates

Table 85. Sanofi Pasteur Corporation Information

Table 86. Sanofi Pasteur Description and Business Overview

Table 87. Sanofi Pasteur Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)

Table 88. Sanofi Pasteur Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Product

Table 89. Sanofi Pasteur Recent Developments/Updates

Table 90. CSL Limited Corporation Information

Table 91. CSL Limited Description and Business Overview

Table 92. CSL Limited Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)

Table 93. CSL Limited Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Product

Table 94. CSL Limited Recent Developments/Updates

Table 95. Emergent Biosolutions Corporation Information

Table 96. Emergent Biosolutions Description and Business Overview

Table 97. Emergent Biosolutions Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)

Table 98. Emergent Biosolutions Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Product

Table 99. Emergent Biosolutions Recent Developments/Updates

Table 100. Serum Institute of India Corporation Information

Table 101. Serum Institute of India Description and Business Overview

Table 102. Serum Institute of India Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)

Table 103. Serum Institute of India Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Product

Table 104. Serum Institute of India Recent Developments/Updates

Table 105. Johnson & Johnson Corporation Information

Table 106. Johnson & Johnson Description and Business Overview

Table 107. Johnson & Johnson Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)

Table 108. Johnson & Johnson Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Product

Table 109. Johnson & Johnson Recent Developments/Updates

Table 110. Key Raw Materials Lists

Table 111. Raw Materials Key Suppliers Lists

Table 112. Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Distributors List

Table 113. Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Customers List

Table 114. Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Trends

Table 115. Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Drivers

Table 116. Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Challenges

Table 117. Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Restraints

Table 118. Research Programs/Design for This Report

Table 119. Key Data Information from Secondary Sources

Table 120. Key Data Information from Primary Sources

List of Figures

Figure 1. Product Picture of Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine

Figure 2. Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Value Comparison by Type (2024-2030) & (US$ Million)

Figure 3. Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Share by Type in 2023 & 2030

Figure 4. Pediatric Hepatitis B (CHO) Vaccine Product Picture

Figure 5. Adult Hepatitis B (CHO) Vaccine Product Picture

Figure 6. Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Value Comparison by Application (2024-2030) & (US$ Million)

Figure 7. Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Share by Application in 2023 & 2030

Figure 8. Hospitals

Figure 9. Clinics

Figure 10. Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue, (US$ Million), 2019 VS 2023 VS 2030

Figure 11. Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Size (2019-2030) & (US$ Million)

Figure 12. Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales (2019-2030) & (K Doses)

Figure 13. Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Average Price (USD/Dose) & (2019-2030)

Figure 14. Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Report Years Considered

Figure 15. Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales Share by Manufacturers in 2023

Figure 16. Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue Share by Manufacturers in 2023

Figure 17. The Global 5 and 10 Largest Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Players: Market Share by Revenue in 2023

Figure 18. Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023

Figure 19. Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Figure 20. North America Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales Market Share by Country (2019-2030)

Figure 21. North America Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue Market Share by Country (2019-2030)

Figure 22. U.S. Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 23. Canada Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 24. Europe Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales Market Share by Country (2019-2030)

Figure 25. Europe Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue Market Share by Country (2019-2030)

Figure 26. Germany Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 27. France Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 28. U.K. Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 29. Italy Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 30. Russia Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 31. Asia Pacific Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales Market Share by Region (2019-2030)

Figure 32. Asia Pacific Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue Market Share by Region (2019-2030)

Figure 33. China Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 34. Japan Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 35. South Korea Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 36. India Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 37. Australia Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 38. Taiwan Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 39. Indonesia Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 40. Thailand Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 41. Malaysia Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 42. Philippines Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 43. Latin America Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales Market Share by Country (2019-2030)

Figure 44. Latin America Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue Market Share by Country (2019-2030)

Figure 45. Mexico Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 46. Brazil Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 47. Argentina Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 48. Middle East & Africa Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales Market Share by Country (2019-2030)

Figure 49. Middle East & Africa Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue Market Share by Country (2019-2030)

Figure 50. Turkey Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 51. Saudi Arabia Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 52. U.A.E Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 53. Global Sales Market Share of Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine by Type (2019-2030)

Figure 54. Global Revenue Market Share of Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine by Type (2019-2030)

Figure 55. Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Price (USD/Dose) by Type (2019-2030)

Figure 56. Global Sales Market Share of Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine by Application (2019-2030)

Figure 57. Global Revenue Market Share of Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine by Application (2019-2030)

Figure 58. Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Price (USD/Dose) by Application (2019-2030)

Figure 59. Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Value Chain

Figure 60. Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Production Process

Figure 61. Channels of Distribution (Direct Vs Distribution)

Figure 62. Distributors Profiles

Figure 63. Bottom-up and Top-down Approaches for This Report

Figure 64. Data Triangulation

Figure 65. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

RELATED REPORTS

Global Dengue Testing Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-26K6048

Mon Apr 15 00:00:00 UTC 2024

Add to Cart

Global Ebola Treatment Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-20L6129

Mon Apr 15 00:00:00 UTC 2024

Add to Cart

Global Cytomegalovirus Infection Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-4F6384

Mon Apr 15 00:00:00 UTC 2024

Add to Cart

Global IVD Infectious Diseases Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-16N6009

Mon Apr 15 00:00:00 UTC 2024

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions